Case Studies of Real-World Brain Sensing Showing Patient-Specific Trends to Inform Therapy Management in Parkinson’s Disease
Objective: Explore the utility of chronic brain sensing in identifying patient-specific trends that could be useful to tailor deep brain stimulation (DBS) in Parkinson’s disease…Climate Change Indices and The Vulnerability of Parkinson’s Patients in The MENA Region And North Africa: A Narrative Review
Objective: Through a (SWOT) analysis, this study looked at the climate change indices and the susceptibility of Parkinson's patients in the MENA region and North…Neuroprotective Action of Exogenous Melatonin in Parkinson Disease Patients and its Impact on Daily Routine: a Systematic Review
Objective: This study aims to evaluate the neuroprotective action of exogenous melatonin in Parkinson disease patients and its impact on daily routine. Background: Parkinson Disease…The “Cat Killer’s Disease”: Lived Experience of Parkinson’s disease Patients in Ethiopia
Objective: The main objective of this study is to explore the lived experience of PD patients in Addis Ababa, Ethiopia. Background: Parkinson's disease (PD) is…Boosting Parkinson’s Disease Diagnosis: How Training Ethiopian Healthcare Workers and Enhancing Community Level Awareness Led to a Surge in Case Identification
Objective: The study assessed the effectiveness of a capacity development training program in improving the diagnosis of Parkinson's Disease (PD) by healthcare professionals Background: Parkinson's…Device-aided Recording of Gait Parameters and Motor Fluctuations in Patients with advanced Parkinson’s disease in the Home Environment
Objective: To objectively assess mobility and gait parameters in the ON and OFF state in patients with advanced Parkinson's disease (PD) under everyday conditions using…Path To Prevention (P2P) Therapeutics Platform Trial in Stage 2B Neuronal Alpha-Synuclein Disease: Study Update
Objective: To describe the study design and timeline of the first interventional study in Neuronal α-Synuclein Disease (NSD). Background: P2P is a platform, Phase 2…Establishing α-Synuclein Seeding Activity in Saliva as a Noninvasive Diagnostic Biomarker for Parkinson’s Disease
Objective: To establish α-synuclein seeding activity in saliva as a noninvasive diagnostic biomarker for Parkinson’s disease (PD). Background: PD is the second most common neurodegenerative…Influence of immigration on Parkinson’s disease: analysis of clinical presentation.
Objective: To analyze the epidemiological and clinical presentation in our immigrants patients with Parkinson’s disease (PD) from our reference population in Barcelona, Spain. Background: In…Cognitive Side Effects to Initial Levodopa Exposure as a “Red Flag”: A Retrospective Study
Objective: To assess if presence of cognitive side effects during an initial levodopa trial suggests the ultimate diagnosis of atypical Parkinson (APD) vs Parkinson disease…
- « Previous Page
- 1
- …
- 117
- 118
- 119
- 120
- 121
- …
- 436
- Next Page »